Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Revolution Medicines
Deal Size : $25.0 million
Deal Type : Collaboration
Revolution & Iambic Announces Collaboration to Pursue New Drug Candidates
Details : Through the collaboration Iambic will use structures and molecular libraries provided by Revolution Medicines to pursue novel drug candidates using Iambic’s leading AI models.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Undisclosed
July 09, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Revolution Medicines
Deal Size : $25.0 million
Deal Type : Collaboration